SNDL Inc. Acquires The Valens Company

SNDL Acquires Remaining Minority Interest in Nova Cannabis

October 21, 2024

Consumer Products

SNDL Inc. completed the previously announced plan of arrangement under which it acquired all of the remaining issued and outstanding shares of Nova Cannabis Inc. that it did not already own, representing about 34.8% of Nova. Under the deal, Nova shareholders received $1.75 per Nova share in cash, with an option to receive SNDL shares in lieu of cash for up to half of the aggregate consideration.

SNDL Acquires Indiva’s Cannabis Edibles Business and Assets

November 4, 2024

Healthcare Services

SNDL Inc. has successfully closed the acquisition of Indiva Limited’s business and assets under Indiva’s CCAA proceedings. The deal includes Indiva’s 40,000-square-foot cannabis edibles production facility in London, Ontario, along with a portfolio of brands and SKUs intended to expand SNDL’s position in the infused edibles category.

Sundial Growers Acquires Alcanna Inc.

October 7, 2021

Retail

Sundial Growers Inc. agreed to acquire all outstanding shares of Alcanna Inc. in an all-stock plan of arrangement valued at approximately C$346 million, giving Alcanna shareholders Sundial common shares. The deal expands Sundial's retail footprint into liquor (Alcanna operates 171 store locations) and increases its exposure to cannabis retail through Alcanna's interest in Nova Cannabis, with expected synergies and improved cash generation.

Flowserve Corporation Acquires Velan Inc. for Approximately $245M

February 10, 2023

Manufacturing

Flowserve Corporation agreed to acquire Velan Inc. in an all-cash transaction valued at approximately $245 million (C$329 million), including assumption of outstanding debt. The acquisition adds Velan's engineered industrial valve products, aftermarket opportunities and technical expertise—particularly in nuclear, cryogenic and defense markets—to Flowserve's Flow Control Division and is expected to deliver cost synergies and be accretive to adjusted EPS in the first full year after close.

Hempsana Holdings Ltd. Completes Acquisition of Hempsana Inc.

July 12, 2021

Pharmaceuticals

Hempsana Holdings Ltd. (formerly Stralak Resource Inc.) completed a previously announced three‑cornered amalgamation to acquire Hempsana Inc., making Hempsana a wholly‑owned subsidiary. The combined company will focus on manufacturing cannabis derivatives and extracts (including vapeables, topicals and infused consumables) from Hempsana's Health Canada standard processing licensed and EU‑GMP‑compliant facility; HHL's shares are expected to trade on the Canadian Securities Exchange under the ticker HMPS.

CV Sciences Acquires Extract Labs

November 21, 2024

Consumer Products

CV Sciences, Inc. entered into a definitive agreement to acquire Extract Labs, Inc., a manufacturer and distributor of premium cannabinoid products, for $400,000 in cash plus $1,000,000 in CV Sciences shares at closing. Additional contingent consideration of up to $600,000 in CV Sciences shares may be earned based on Extract Labs revenue targets post-closing, which is expected in Q1 2025.